Last week Tim Cook told the Wall Street Journal that Apple Apple bought back $14 billion worth of stock in the two weeks following its fourth-quarter earnings release. Now the billionaire campaigning for a far bigger distribution of cash from the iPhone maker is laying down his sword.
Carl Icahn issued a letter to Apple shareholders Monday morning that effectively declares detente. The legendary investor, who had been campaigning for a massive buyback from the company, is backing down after shareholder advisory service ISS sided with Apple and recommended shareholders vote against Icahn’s proposal that urged an additional $50 billion share repurchase.
Icahn’s letter (posted to his Shareholders Square Table website), cites ISS’ finding that with the recent stock buybacks Apple is well on its way to repurchasing at least $32 billion in stock this year, not far off the billionaire’s demands.
“[I]n light of Tim Cook’s confirmed plan to launch new products in new categories this year (in addition to an exciting product roadmap with respect to new products in existing categories), we are extremely excited about Apple’s future,” Icahn writes. ” Additionally, we are pleased that Tim and the board have exhibited the “opportunistic” and “aggressive” approach to share repurchases that we hoped to instill with our proposal.”
5 Best Safest Stocks To Invest In Right Now: Agility Public Warehousing Co KSC (AGLTY)
Agility Public Warehousing Company KSC is a Kuwait-based company engaged, along with its subsidiaries, in the provision of global integrated logistics solutions. The Company is organized into two business segments: the Logistic and Related services segment provides logistics offering to its clients, including freight forwarding, transportation, contract logistics, project logistics and fairs and events logistics, and the Infrastructure segment provides other services, which include industrial real estate airport and airplane ground handling and cleaning services, customs consulting, private equity and waste recycling. The Company operates under the brand name of Agility. The Company’s subsidiaries include Global Express Transport Co. WLL, PWC Transport Company WLL, Agility DGS Logistics Services KSCC and Gulf Catering Company for General, among others. Advisors’ Opinion:
- [By Fiona MacDonald]
The Kuwait SE Price Index rose for a sixth day, climbing 0.5 percent to 6,851.17 at the close. Kuwait Real Estate Co. (KRE) climbed to the highest level in a month. Agility (AGLTY) advanced 1.7 percent after winning a $190 million UN contract in Sudan’s Darfur region. The Bloomberg GCC 200 Index, which tracks the biggest 200 companies in the Gulf Cooperation Council, fell 0.1 percent.
5 Best Safest Stocks To Invest In Right Now: China Finance Online Co. Limited(JRJC)
China Finance Online Co. Limited provides integrated financial products and services in the People?s Republic of China. It offers various financial services, including news, data, analytics, and brokerage-related services through Web portals, desktop solutions, and mobile handsets. The company?s Web portals comprise jrj.com and stockstar.com, which offer subscription-based service packages that integrate financial and listed company data, information, and analytics from various sources with features and functions, such as data and information search, retrieval, delivery, storage, and analysis to individual users and institutional customers, including domestic securities and investment firms. It also collects, processes, and provides financial analysis tools, real-time and historical data, news, research reports, and online forums in one integrated information platform that allows its subscribers to make investment decisions with respect to various listed company stocks, bo nds, mutual funds, and stock index futures. In addition, the company?s financial analysis tools offer subscribers with the ability to calculate and analyze financial data, such as securities market data analysis tools; technical analysis; and fundamental analysis. Further, it provides securities brokerage and online advertisement services. The company offers its products and services through its Websites, telemarketing, and customer service centers to individual investors managing their own money; professional investors, including institutional investors managing money on behalf of their clients and high net worth individuals; and other financial professionals, such as investment bankers, stock analysts, financial reporters, and middle class individuals. China Finance Online Co. Limited has strategic alliances with China Center for Financial Research of Tsinghua University and China Telecom. The company was founded in 1998 and is based in Beijing, the People?s Republic o f C hina.
- [By Lisa Levin]
China Finance Online Co (NASDAQ: JRJC) shares reached a new 52-week high of $6.85 after the company reported its Q3 unaudited financial results.
Avis Budget Group (NASDAQ: CAR) shares touched a new 52-week high of $41.03. Avis Budget shares have jumped 94.61% over the past 52 weeks, while the S&P 500 index has gained 24.92% in the same period.
- [By Monica Gerson]
China Finance Online Co (NASDAQ: JRJC) is expected to post its Q4 earnings.
Stanley Furniture Co (NASDAQ: STLY) is estimated to post a Q3 loss at $0.11 per share on revenue of $25.32 million.
5 Best Safest Stocks To Invest In Right Now: Roche Holding AG (RHHBY)
Roche Holding AG is a Switzerland-based pharmaceuticals and diagnostics company. The Company belongs to the Roche Group that operates through numerous subsidiaries and associated companies located around the world. The Company’s products and services cover every stage of the healthcare process, from identifying disease susceptibilities and testing for disease in at-risk populations to prevention, diagnosis, therapy and treatment monitoring. Roche operates through two divisions: Pharmaceuticals and Diagnostics. Within the Pharmaceuticals Division there are three sub-divisions: Roche Pharmaceuticals, Genentech and Chugai. The Company’s Diagnostics Division includes five sub-divisions: Applied Science, Diabetes Care, Molecular Diagnostics, Tissue Diagnosis and Professional Diagnostics. Its activities are structured into six geographical segments: North America; Asia-Pacific; Western Europe; Latin America; Central and Eastern Europe, Middle East and Africa (CEMAI), and Jap an. In March 2009, the Company completed the acquisition of Genentech, Inc. In March 2010, the Company acquired assets from BioMicro Systems for all products associated with the Roche NimbleGen microarray workflow.
During the year ended December 31, 2008, the Company Pharmaceuticals Division marketing gained approvals for its rheumatoid arthritis medicine Actemra/RoActemra in Japan, Switzerland and the European Union. In 2008, the division initiated 12 new phase III projects in, including clinical trials of the compounds pertuzumab, for breast cancer; taspoglutide, for type two diabetes, and dalcetrapib, for cardiovascular risk reduction. As of December 31, 2008, the Pharmaceuticals Division filed 11 major new marketing applications and gained 13 major regulatory approvals. At the beginning of 2009, the division’s research and development pipeline comprised 120 clinical projects, including 62 new molecular entities (NMEs) and 58 additional indications. Forty N MEs are in phase I, 16 in phase II and six in phase III or f! iled for regulatory review.
In 2008, Roche Pharmaceuticals signed a total of 57 new agreements including seven product transactions and 43 research and technology collaborations. In May 2008, Roche acquired Piramed Limited, a UK company with therapeutic research programmes targeting the PI3-kinase pathway in oncology and inflammatory disease. In June 2008, signed licensing agreement with ThromboGenics and BioInvent for their jointly developed anticancer agent TB-403 (R7334). In September, 2008, the Company acquired Mirus Bio Corporation active in the field of ribonucleic acid interference (RNAi) delivery and completed the acquisition of ARIUS Research Inc., which has a antibody platform that identifies and selects antibodies based on their functional ability to affect disease. S Research Inc. In January 2009, Roche acquired Memory Pharmaceuticals, which develops drug candidates for the treatment of debilitating central nervous system disorders such as Alzheimer ’s disease and schizophrenia.
Within Pharmaceuticals division, the Company is engaged in the provision of drugs the areas of oncology, anemia, cardiovascular diseases, central nervous system, infectious diseases, inflammatory and autoimmune diseases, metabolic disorders, cancer, transplantation and virology. The products offered by Roche’s Pharmaceuticals division include MabThera/Rituxan, Herceptin, Avastin, Tamiflu, CellCept, NeoRecormon, Epogin, Pegasys, Tarceva, Xeloda, Bonviva, Boniva, Lucentis, Tamiflu, Xolair, Valcyte, Cymevene, Xenical, Pulmozyme, Nutropin, Neutrogin, Rocephin, Activase, TNKase and Madopar. The products offered by the Pharmaceuticals division are sold in seven geographic regions: North America; Asia-Pacific; Western Europe; Latin America; Central and Eastern Europe, Middle East and Africa (CEMAI), and Japan.
Roche’s Diagnostics Division is a supplier of in vitro dia gnostics (IVDs). Its products are used to test body fluids a! nd tissue! samples to obtain information for the purpose of preventing, diagnosing, treating and monitoring disease. The Company has business areas five within the diagnostics division: Professional Diagnostics, Diabetes Care, Tissue Diagnostics, Molecular Diagnostics and Applied Science. Roche’s Diagnostics division provides IVD services, including centralized laboratory testing and point-of-care diagnostics to molecular diagnostics and diabetes self management. In addition, it supplies research tools to life scientists.
Roche Professional Diagnostics supplies instrument systems, tests, software and services. It provides point-of-care testing products to support clinical decision-making close to the patient, in doctors’ offices, emergency rooms and other primary and specialty care settings. Twelve Serum Work Area assays were rolled out during the year ended December 31, 2008, across Europe and in other markets. New assays included the Elecsys anti-TSH receptor antib ody assay for the diagnosis of Graves’ disease the Elecsys anti-CCP antibody assay, a test to aid the diagnosis of rheumatoid arthritis, and the Roche Cystatin C clinical chemistry test for early detection of impaired kidney function, among others. Roche Diabetes Care’s products portfolio covers the entire diabetes self-management spectrum, from glucose monitoring to insulin delivery, as well as monitoring systems with integrated lancets and test strips software for storing and analyzing data. Roche Tissue Diagnostics develops and manufactures medical diagnostic instruments and reagent systems that provide automation technology for use in the diagnosis and prognosis of cancer and infectious disease. In 2008 Roche Tissue Diagnostics launched ofhe Bench- Mark Ultra, a system that performs immunohistochemistry and in situ hybridisation testing simultaneously on a single continuous and random access platform. Roche Molecular Diagnostics develops and commercializes diagnostic and blood screening platforms and tests based on Roche’s ! real-time! polymerase chain reaction (PCR) technology. Applied Science business area supplies a specific reagents and test kits for use in life sciences encompassing biology, biotechnology ,medical research, as well as disease areas like cancer and virology. Applied Science’s business area product portfolio includes such sequencing systems as LightCycler 480, LightCycler 480 II, GS FLX Titanium. In addition, Applied Science offers xCELLigence cell analyzer.
- [By James E. Brumley]
I hate to be the one to say I told you so, but, I told you so. Back on February 26th I suggested IsoRay, Inc. (NYSEMKT:ISR) shares were a budding breakout play. The 48% rally that’s played out for ISR in the meantime unfurled right on cue. While overbought in the very short run, this small cap stock looks like it’s earning the right to be compared to the likes of bigger brothers in the cancer-treatment space… names like Roche Holding Ltd. (OTCMKTS:RHHBY) or Theragenics Corporation (NYSE:TGX).
- [By Bryan Murphy]
No, it’s no Amgen, Inc. (NASDAQ:AMGN) yet, and it’s not ready to go toe-to-toe with Roche Holding Ltd. (OTCMKTS:RHHBY) either. But, when you read between the lines with TNI Biotech Inc. (OTCMKTS:TNIB) – or take a big step back and look at the bigger picture for TNIB – you have to wonder if it’s now a better investment opportunity than RHHBY or AMGN are.
- [By Michael Robinson]
In December, Prothena signed a deal with drug giant Roche Holding AG (RHHBY) to develop and commercialize Parkinson’s treatments that could be worth up to $600 million.
5 Best Safest Stocks To Invest In Right Now: PTC Therapeutics Inc (PTCT)
PTC Therapeutics, Inc., incorporated on March 31, 1998 , is a biopharmaceutical company focused on the discovery and development of orally administered, small-molecule drugs that target post-transcriptional control processes. The Company’s lead product candidate includes ataluren, which is used for the treatment of patients with genetic disorders that arise from a type of genetic mutation known as a nonsense mutation. Ataluren is in late stage clinical development for the treatment of Duchenne muscular dystrophy caused by nonsense mutations (nmDMD) and cystic fibrosis caused by nonsense mutations (nmCF).
Ataluren is orally administered small-molecule compound that targets nonsense mutations. The Company is engaged in the development of ataluren for the treatment of genetic disorders in, which a nonsense mutation is the cause of the disease. Genetic tests are available for many genetic disorders, including Duchenne muscular dystrophy and cystic fibrosis, to d etermine if the underlying cause is a nonsense mutation. The EMA has designated ataluren as an orphan medicinal product for the treatment of nmDMD and nmCF. During the year ended December 31, 2012, the Phase III clinical trial completed. The Company’s Ataluren clinical trials in patients with nonsense mutation genetic disorders include Ataluren for nmDMD: Phase 2b clinical trial complete; Confirmatory Phase III clinical trial initiated, and Ataluren for nmCF: Phase III trial completed.
- [By John Kell]
PTC Therapeutics Inc.(PTCT) said the European Medicines Agency’s Committee for Medicinal Products for Human Use issued a negative opinion on the biopharmaceutical company’s marketing authorization application for its muscular dystrophy treatment. Shares slumped 21% to $20.60 in premarket trading.
5 Best Safest Stocks To Invest In Right Now: Bhp Billiton PLC (BBL)
BHP Billiton plc, incorporated in 1996, is diversified natural resources company. The Company generally operates through customer sector groups (CSGs). The Company operates in nine segments: Petroleum, Aluminium, Base Metals, Diamonds and Specialty Products, Stainless Steel Materials, Iron Ore, Manganese, Metallurgical Coal and Energy Coal. As of June 30, 2012, the Company was working in more than 100 locations worldwide. During the fiscal year ended June 30, 2012 (fiscal 2012), the Company total petroleum production was 222.3 millions of barrels of oil equivalent. During fiscal 2012, its aluminium had a total production in 1.2 million tones (Mt) of aluminium. In August 2011, the Company acquired Petrohawk Energy Corporation. On September 30, 2011, it acquired HWE Mining Subsidiaries from Leighton Holdings. On September 7, 2012, the Company announced the sale of its 37.8 % non-operated interest in Richards Bay Minerals.
Petroleum Customer Sector Group
The Company’s petroleum customer sector group (CSG) consists of a base of onshore and offshore operations that are located in six countries throughout the world. The Company’s production operations include Bass Strait, North West Shelf, Australia operated, Gulf of Mexico, Onshore United States, Liverpool Bay and Bruce/Keith, Algeria, Trinidad and Tobago and Zamzama. Together with its 50-50 joint venture Esso Australia (a subsidiary of ExxonMobil), the Company has been producing oil and gas from Bass Strait, off the south-eastern coast of Australia. The Company dispatches the majority of its Bass Strait crude oil and condensate production to refineries along the east coast of Australia. Gas is piped onshore to its Longford processing facility, from which it sells the Company’s production to domestic distributors under contracts with periodic price reviews.
The Company is a joint venture participant in the North West Shelf Project in Western Australia. The North West Shelf Project was developed in phases the do! mestic gas phase supplies gas to the Western Australian domestic market mainly under long-term contracts, and a series of liquefied natural gas (LNG) expansion phases supplying LNG to buyers in Japan, Korea and China under a series of long-term contracts. The project also produces liquefied petroleum gas LPG and condensate. The Company is also a joint venture participant in four nearby oil fields. Both the North West Shelf gas and oil ventures are operated by Woodside.
The Company operates two oil fields offshore Western Australia and one gas field in Victoria. The Pyrenees oil development consists of three fields, two of which (Crosby and Stickle) are located in blocks WA-42-L, while the third (Ravensworth) straddles blocks WA-42-L and WA-43-L. The project uses a FPSO facility. The Stybarrow operation is an oil development located offshore Western Australia. The Minerva operation is a gas field located offshore Victoria. The operation consists of two subsea pro ducing wells which pipe gas onshore to a processing plant. The gas is delivered into a pipeline and sold domestically.
The Company operates two fields in the Gulf of Mexico (Neptune and Shenzi) and hold non-operating interests in a further three fields (Atlantis, Mad Dog and Genesis). The Company divested its interest in the West Cameron and Starlifter areas in June 2012. The Company delivers its oil production to refineries along the Gulf Coast of the United States. The Company operates in four shale fields located onshore in the United States Fayetteville, Eagle Ford, Haynesville and Permian. The combined leasehold acreage of the Onshore United States fields is approximately 1.6 million net acres in the states of Texas, Louisiana and Arkansas. Its ownership interests range from less than 1% to 100%. During fiscal 2012, the Onshore United States business delivered 6.9 million barrels of crude oil and condensates, 448 billion cubic feet of natural gas and four m illion barrels of natural gas liquids.
The Liv! erpool Ba! y, United Kingdom, integrated development consists of five producing offshore gas and oil fields in the Irish Sea, the Point of Ayr onshore processing plant in north Wales and associated infrastructure. The Company delivers the Liverpool Bay gas by pipeline to E.ON’s Connah’s Quay power station. The Company owns 46.1% of and operates Liverpool Bay. It also holds a 16% non-operating interest in the Bruce oil and gas field in the North Sea and operates the Keith field, a subsea tie-back, which is processed via the Bruce platform facilities.
The Company’s Algerian operations consists its 38% interest in the ROD Integrated Development, which consists of six satellite oil fields that pump oil back to a dedicated processing train. The Company exited its effective 45 % interest in the Ohanet wet gas development in October 2011. The Greater Angostura project is integrated oil and gas development located offshore east Trinidad. The Company operates the field and h as a 45% interest in the production sharing contract for the project. The Company holds a 38.5 % working interest in and operates the Zamzama gas project in Sindh province of Pakistan. Both gas and condensate are sold domestically.
Aluminium Customer Sector Group
The Company’s Aluminium customer sector groups (CSG) is a portfolio of assets at three stages of the aluminium value chain, such as mining bauxite, refining bauxite into alumina, and smelting alumina into aluminium metal. The Company also produced 12.8 metric ton of bauxite and 4.2 metric ton of alumina. Its Boddington/Worsley is an integrated bauxite mining/alumina refining operation. The Boddington bauxite mine in Western Australia supplies bauxite ore to the Worsley alumina refinery via a 62-kilometre long conveying system. It is the Company’s sole integrated bauxite mining/alumina refining asset. The Company owns 14.8 % of Mineracao Rio do Norte (MRN), which owns and operates a lar ge bauxite mine in Brazil.
The Company’s Alumar! is an in! tegrated alumina refinery/aluminium smelter. The Company owns 36 % of the Alumar refinery and 40 % of the smelter. Alcoa operates both facilities. The operations, and their integrated port facility, are located at Sao Luis in the Maranhao province of Brazil. Alumar sources bauxite from MRN. During fiscal 2012, approximately 27 % of Alumar’s alumina production was used to feed the smelter, while the remainder was exported. Its Hillside and Bayside smelters are located at Richards Bay, South Africa. It has a capacity of approximately 715 kiloton’s per annum. Hillside imports alumina from its Worsley refinery. The Company owns 47.1 % of and operates the Mozal aluminium smelter in Mozambique, which has a total capacity of approximately 563 kiloton’s per annum. Mozal sources power generated by Hydro Cahora Basa via Motraco, a transmission joint venture between Eskom and the national electricity utilities of Mozambique and Swaziland.
Base Metals Customer Sector Group
The Company’s Base Metals CSG is producers of copper, silver, lead and uranium, and a producer of zinc. Its portfolio of mining operations includes the Escondida mine in Chile and Olympic Dam in South Australia. Its total copper production during fiscal 2012, was 1.1 metric ton. In addition to conventional mine development, it pursue advanced treatment technologies, such as leaching low-grade chalcopyrite ores. The Company markets five primary products, such as copper concentrates, copper cathodes, uranium oxide, lead concentrates and zinc concentrates.
The Company has 57.5% interest owned and operated Escondida mine. During fiscal 2012, its share of Escondida production was 333.8 kiloton of payable copper in concentrate and 172.0 kiloton of copper cathode. Its Olympic Dam is a producer of copper cathode and uranium oxide and a refiner of smaller amounts of gold and silver bullion. The Company owns 33.75 % of Antamina copper/zinc mine in Pe ru. The Company’s wholly owned Spence copper mine produces! copper c! athode. During fiscal 2012, the Company produced 180.3 kiloton of copper cathode. The Company also has interest in Pampa Norte Cerro Colorado Operation, Cannington and North America-Pinto Valley.
Diamonds and Specialty Products Customer Sector Group
The Company’s diamonds and specialty products CSG operate its diamonds business and engage in the exploration and development of a potash business. Its diamonds business is consists of the EKATI Diamond Mine in the Northwest Territories of Canada. The Company’s interest in EKATI consists of an 80%t interest in the Core Zone Joint Venture, consisting existing operations and a 58.8 % interest in the Buffer Zone Joint Venture, primarily focusing on exploration targets. The Company sells its rough diamonds to international diamond buyers through its Antwerp sales office.
Stainless Steel Materials Customer Sector Group
The Company’s Stainless Steel Materials CSG is primarily a supplier of nickel to the stainless steel industry. The Company also supplies nickel to other markets, including the specialty alloy, foundry, chemicals and refractory material industries. The Company’s nickel business consists of two assets, including Nickel West and Cerro Matoso. Nickel West is the name for its wholly owned Western Australian nickel Asset, which consists of an integrated system of mines, concentrators, a smelter and a refinery. The Company mine nickel-bearing sulphide ore at its Mt Keith, Leinster and Cliffs Operations north of Kalgoorlie. The Company operates concentrator plants at Mt Keith and at Leinster, which also concentrate ore from Cliffs. The Company also operates the Kambalda concentrator south of Kalgoorlie, where it source ore through tolling and concentrate purchase arrangements with third parties in the Kambalda region. The Company’s Cerro Matoso is its 99.94 % owned nickel Asset in Colombia, combines a lateritic nickel ore deposit with a ferronickel smelter. Production in during fiscal 2012, was! 48.9 kil! oton of nickel in ferronickel form.
Iron Ore Customer Sector Group
The Company’s Iron Ore CSG consists of its Western Australia Iron Ore (WAIO) interests and a 50 % interest in the Samarco Joint Venture in Brazil. The Company sells lump and fines product produced in Australia and pellets from its operations in Brazil. WAIO’s operations involve integrated system of mines and more than 1,000 kilometers of rail infrastructure and port facilities in the Pilbara region of northern Western Australia. WAIO operations consist of three joint ventures, such as Mt Newman, Yandi and Mt Goldsworthy and Jimblebar. The Company is a joint venture partner with Vale at the Samarco Operation in Brazil. Samarco consists of a mine and two concentrators located in the State of Minas Gerais, and three pellet plants and a port located in the State of Espirito Sant.
Manganese Customer Sector Group
The Company’s Manganese CSG produces a combi nation of ores and alloys from sites in South Africa and Australia. Aproximately 80 % of its ore production is sold directly to external customers and the remainder is used as feedstock in its alloy smelters. The Company owns and manages all manganese mining operations and alloy plants through joint ventures with Anglo American. Its joint venture interests are held through Samancor Manganese, which operates its global Manganese assets. In South Africa, Samancor Manganese (Pty) Ltd owns 74 % of Hotazel Manganese Mines (Pty) Ltd (HMM) and 100 % of the Metalloys division. In Australia, it owns 60 % of Groote Eylandt Mining Company Pty Ltd (GEMCO) and has an effective interest of 60 % in Tasmanian Electro Metallurgical Company Pty Ltd (TEMCO) through GEMCO, which owns 100 % of TEMCO.
Metallurgical Coal Customer Sector Group
The Company’s Metallurgical Coal CSG is a supplier of seaborne metallurgical coal. Metallurgical coal, along with iron ore and ma nganese, is a key input in the production of steel. The Comp! any’s e! xport customers are steel producers around the world. The Company has assets in two resource basins, such as the Bowen Basin in Central Queensland, Australia, and the Illawarra region of New South Wales, Australia.
The Bowen Basin is well positioned to supply the seaborne market. The Company also has access to key infrastructure, including a modern, integrated electric rail network and its own coal loading terminal at Hay Point, Mackay. The Company owns and operates three underground coal mines in the Illawarra region of New South Wales, which supply metallurgical coal to the nearby BlueScope Port Kembla steelworks, and other domestic and export markets. Total production in during fiscal 2012, was approximately 7.9 metric ton.
Energy Coal Customer Sector Group
The Company’s Energy Coal CSG is a producers and marketers of export energy coal (also known as thermal or steaming coal) and is also a domestic supplier to the electricity gen eration industry in Australia, South Africa and the United States. The Company makes export sales to power generators and some industrial users in Asia, Europe and the United States, usually under contracts for delivery of a fixed volume of coal. The Company operates three assets, including a group of mines and associated infrastructure collectively known as BHP Billiton Energy Coal South Africa; its New Mexico Coal operations in the United States; and its New South Wales Energy Coal operations in Australia. The Company also owns a 33.33 % share of the Cerrejon Coal Company, which operates a coal mine in Colombia.
BHP Billiton Energy Coal South Africa (BECSA) operates four coal mines being Khutala, Klipspruit, Middelburg and Wolvekrans in the Witbank region of Mpumalanga province of South Africa. The Company owns and operates the Navajo mine, located on Navajo Nation land in New Mexico, and the nearby San Juan mine located in the state of New Mexico. Each mine t ransports its production directly to a nearby power station.! New Sout! h Wales Energy Coal’s operating asset is the Mt Arthur Coal open-cut mine in the Hunter Valley region of New South Wales, which produced approximately 17 metric ton during fiscal 2012. The Company has a one-third interest in Cerrejon Coal Company, which owns and operates open-cut export coal mines in La Guajira province of Colombia, as well as integrated rail and port facilities through which the majority of production is exported to European, Middle Eastern, North American and Asian customers.
- [By Roland Head]
LONDON — After making strong gains toward the end of last year, shares in miners Rio Tinto (LSE: RIO ) (NYSE: RIO ) and BHP Billiton (LSE: BLT ) (NYSE: BBL ) have fallen by around 10% since the beginning of 2013.
- [By Roland Head]
Today, I’m going to take a look at global mining giant BHP Billiton (LSE: BLT ) (NYSE: BBL ) and its much smaller, US-based peer Cliffs Natural Resources (NYSE: CLF ) , which is the largest producer of iron ore in the U.S. and has an Australian mine that exports iron ore to China, in competition with BHP.